DPI
ABBV icon

Diversified Portfolios Inc’s AbbVie ABBV Stock Holding History

Diversified Portfolios Inc’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.06M Sell
4,893
-801
-14% -$178K 0.09% 95
2025
Q4 		$1.3M Buy
5,694
+525
+10% +$120K 0.11% 85
2025
Q3 		$1.2M Sell
5,169
-61
-1% -$12.4K 0.11% 82
2025
Q2 		$971K Buy
5,230
+69
+1% +$12.8K 0.09% 86
2025
Q1 		$1.08M Sell
5,161
-222
-4% -$43.2K 0.11% 81
2024
Q4 		$957K Sell
5,383
-246
-4% -$45.2K 0.1% 80
2024
Q3 		$1.11M Buy
5,629
+2
+0% +$373 0.12% 76
2024
Q2 		$965K Sell
5,627
-2,694
-32% -$446K 0.13% 78
2024
Q1 		$1.52M Sell
8,321
-366
-4% -$63.1K 0.21% 56
2023
Q4 		$1.35M Sell
8,687
-17
-0.2% -$2.48K 0.21% 54
2023
Q3 		$1.3M Buy
8,704
+17
+0.2% +$2.5K 0.24% 50
2023
Q2 		$1.17M Sell
8,687
-501
-5% -$73.5K 0.23% 54
2023
Q1 		$1.46M Hold
9,188
– – 0.33% 45
2022
Q4 		$1.48M Sell
9,188
-130
-1% -$19.9K 0.34% 39
2022
Q3 		$1.25M Sell
9,318
-1,591
-15% -$228K 0.34% 42
2022
Q2 		$1.67M Sell
10,909
-500
-4% -$76.4K 0.47% 36
2022
Q1 		$1.85M Sell
11,409
-222
-2% -$32.2K 0.44% 38
2021
Q4 		$1.57M Hold
11,631
– – 0.38% 41
2021
Q3 		$1.25M Hold
11,631
– – 0.35% 38
2021
Q2 		$1.31M Buy
11,631
+4,492
+63% +$506K 0.49% 28
2021
Q1 		$773K Buy
7,139
+4,373
+158% +$468K 0.25% 45
2020
Q4 		$296K Hold
2,766
– – 0.11% 75
2020
Q3 		$242K Buy
+2,766
New +$260K 0.1% 64
2015
Q1 		– Sell
-11,118
Closed -$728K – 54
2014
Q4 		$728K Buy
+11,118
New +$701K 0.43% 26

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Diversified Portfolios Inc's ABBV Position: Q1 2026 in Review

Diversified Portfolios Inc reduced its AbbVie (ABBV) stake by 14% in Q1 2026, selling an estimated $178K and leaving 4,893 shares worth $1.06M. The position accounts for 0.09% of the portfolio, ranked #95.

Diversified Portfolios Inc first reported a position in ABBV in Q4 2014 and has held it in 24 quarters since. The position peaked at $1.85M in Q1 2022. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Diversified Portfolios Inc held 4,893 shares of AbbVie worth $1.06M as of Q1 2026.
  • Diversified Portfolios Inc sold 801 AbbVie shares in Q1 2026, an estimated $178K.
  • AbbVie made up 0.09% of Diversified Portfolios Inc's portfolio in Q1 2026, its #95 holding.
  • Diversified Portfolios Inc first reported a position in AbbVie in Q4 2014 and has held it in 24 quarters since.
  • Diversified Portfolios Inc's AbbVie position peaked at $1.85M in Q1 2022.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Diversified Portfolios Inc's 13F filing for Q1 2026, filed 6 May 2026.